The Brazilian Health Surveillance (Anvisa) have an open public consultation related to a proposal of implantation of the National System of Biovigilance, that will make the permanent monitoring of adverse events related to the treatments that require the donation and the transplant of organs or the use of cells and tissues humans. The proposal is to form a national network that identifies risk situations and obtain information related to the occurrence of serious cases, such as the transmission of diseases in donors and recipients.
The objective is to have a database that helps in the decision making of health professionals, preventing new occurrences or even the recurrence of reported cases.
